Pediatric Cardiology, Arkansas Children's Hospital, Little Rock, Arkansas, USA.
Department of Pediatrics, Division of Pediatric Cardiology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Catheter Cardiovasc Interv. 2021 Sep;98(3):526-532. doi: 10.1002/ccd.29803. Epub 2021 Jun 10.
To identify medium-term results following cutting balloon angioplasty (CBA) for branch pulmonary artery stenosis (PAS) and predictors of successful intervention.
CBA has emerged as a successful alternative therapy for PAS resistant to conventional balloon angioplasty techniques but there is little information on medium and long-term outcomes.
This is a descriptive, single center, retrospective chart review of pediatric patients who underwent CBA for PAS at Arkansas Children's Hospital between May 2005 and December 2020. We reviewed demographics, procedural specifics, and 30-day complications.
Forty-four patients underwent pulmonary artery CBA on 114 pulmonary artery segments through 126 catheterization cases, totaling 148 CBA events. Thirty-three individual pulmonary arteries underwent repeat intervention. Average minimal luminal diameter increase from pre-CBA to end of follow-up was 57% (CI, 38%-75%). Absence of Tetralogy of Fallot with pulmonary atresia and major aortopulmonary collateral arteries (TOF/PA/MAPCAs) and the absence of Alagille Syndrome, Williams Syndrome, or Arterial Tortuosity Syndrome (ATS) were associated with increased odds of sustained success by 70% (CI, 0.11-0.79) and 91% (CI, 0.02-0.56), respectively. Increasing the cutting balloon diameter-to-minimal luminal diameter ratio by 0.5 increased odds of successful intervention by 2.37-fold (CI, 1.7-3.3). Seven patients had 30-day complications including one death.
In the longest follow-up to date of children and adolescents who underwent CBA for branch PAS, we found that there was moderate medium-term success. Additionally, absence of TOF/PA/MAPCAs, absence of Alagille Syndrome, Williams Syndrome, or ATS, and high cutting balloon diameter-to-minimal luminal diameter ratio are predictors of sustained results.
确定经皮腔内切割球囊血管成形术(CBA)治疗肺分支动脉狭窄(PAS)的中期结果,以及预测成功干预的指标。
CBA 已成为治疗对传统球囊血管成形术技术有抵抗性的 PAS 的成功替代疗法,但关于中、长期结果的信息很少。
这是一项描述性、单中心、回顾性图表研究,研究对象为 2005 年 5 月至 2020 年 12 月期间在阿肯色儿童医院接受 CBA 治疗 PAS 的儿科患者。我们回顾了人口统计学、手术细节和 30 天并发症。
44 名患者的 114 个肺动脉段共 126 个导管插入术中接受了肺动脉 CBA,总共进行了 148 次 CBA 操作。33 个单独的肺动脉进行了重复干预。CBA 前至随访结束时最小管腔直径增加的平均值为 57%(CI,38%-75%)。无法洛四联症伴肺动脉闭锁和主要体肺侧支动脉(TOF/PA/MAPCAs),以及无 Alagille 综合征、威廉姆斯综合征或动脉迂曲综合征(ATS)与持续成功的几率增加 70%(CI,0.11-0.79)和 91%(CI,0.02-0.56)相关。切割球囊直径与最小管腔直径比值增加 0.5 倍,成功干预的几率增加 2.37 倍(CI,1.7-3.3)。7 名患者在 30 天内发生并发症,包括 1 例死亡。
在迄今为止对接受 CBA 治疗肺分支 PAS 的儿童和青少年进行的最长随访中,我们发现存在中等程度的中期成功。此外,无 TOF/PA/MAPCAs、无 Alagille 综合征、威廉姆斯综合征或 ATS 以及高切割球囊直径与最小管腔直径比值是持续结果的预测指标。